|22.72||+0.49 / +2.20%|
Data as of 3:59pm ET
|22.23||-0.4865 / -2.14%|
The 7 analysts offering 12-month price forecasts for Hyperion Therapeutics Inc have a median target of 35.00, with a high estimate of 40.00 and a low estimate of 32.00. The median estimate represents a +54.05% increase from the last price of 22.72.
The current consensus among 7 polled investment analysts is to Buy stock in Hyperion Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.